AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

STRATEC SE

Declaration of Voting Results & Voting Rights Announcements Oct 8, 2012

416_dva_2012-10-08_1d35bfc9-16df-425e-981e-979f1ac8d3d1.html

Declaration of Voting Results & Voting Rights Announcements

Open in Viewer

Opens in native device viewer

News Details

Voting Rights Announcements | 8 October 2012 20:08

STRATEC Biomedical AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

STRATEC Biomedical AG

08.10.2012 20:08

Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.


  1. Threadneedle Asset Management Holdings SARL

Threadneedle Asset Management Holdings SARL, Luxembourg, Luxembourg, has
notified us pursuant to sec. 21 para. 1 WpHG on 5 October 2012, that on 4
October 2012 the share of voting rights in STRATEC Biomedical AG,
Birkenfeld, Germany, ISIN: DE0007289001 went below the threshold of 5% and
that the percentage of voting rights on that day amounted to 4.90% (575,347
voting rights).
Threadneedle Asset Management Holdings SARL has notified us that these
voting rights of 4.90% (575,347 voting rights) are attributable to
Threadneedle Asset Management Holdings SARL pursuant to sec. 22 para. 1
sent. 1 no. 6 in connection with sent. 2 WpHG.
The voting rights were attributed to Threadneedle Asset Management Holdings
SARL inter alia from Threadneedle Investment Funds ICVC, being a
shareholder holding 3% or more of the voting rights in STRATEC Biomedical
AG.

  1. Ameriprise Financial, Inc.

Ameriprise Financial, Inc., Minneapolis, Minnesota, USA, has notified us
pursuant to sec. 21 para. 1 WpHG on 5 October 2012, that on 4 October 2012
the share of voting rights in STRATEC Biomedical AG, Birkenfeld, Germany,
ISIN: DE0007289001 went below the threshold of 5% and that the percentage
of voting rights on that day amounted to 4.96% (582,627 voting rights).
Ameriprise Financial, Inc. has notified us that these voting rights of
4.96% (582,627 voting rights) are attributable to Ameriprise Financial,
Inc. pursuant to sec. 22 para. 1 sent. 1 no. 6 in connection with sent. 2
WpHG.
The voting rights were attributed to Ameriprise Financial, Inc. inter alia
from Threadneedle Investment Funds ICVC, being a shareholder holding 3% or
more of the voting rights in STRATEC Biomedical AG.

08.10.2012 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de


Language: English
Company: STRATEC Biomedical AG
Gewerbestr. 37
75217 Birkenfeld
Germany
Internet: www.stratec.com

End of Announcement DGAP News-Service


Talk to a Data Expert

Have a question? We'll get back to you promptly.